Protalix BioTherapeutics Stock (AMEX: PLX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 361.62K |
Day Range | - - - |
52 Wk Range | 0.82 - 1.90 |
Market Cap | $80.90M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 58 |
Short Interest | 4.87% |
Days to Cover | 26.04 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Protalix BioTherapeutics (AMEX:PLX) through any online brokerage.
Other companies in Protalix BioTherapeutics’s space includes: Renovaro (NASDAQ:RENB), bluebird bio (NASDAQ:BLUE), Cellectar Biosciences (NASDAQ:CLRB), Armata Pharmaceuticals (AMEX:ARMP) and Gritstone Bio (NASDAQ:GRTS).
Protalix BioTherapeutics has a consensus price target of $10.00.
The stock price for Protalix BioTherapeutics (AMEX: PLX) is $1.1 last updated September 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Protalix BioTherapeutics.
Protalix BioTherapeutics’s Q3 earnings are confirmed for Monday, November 4, 2024.
There is no upcoming split for Protalix BioTherapeutics.
Protalix BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.